Bryn Mawr Trust »

Kalvista Pharmaceuticals shares owned by Bryn Mawr Trust

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Bryn Mawr Trust from 13F filings

Historical chart of Bryn Mawr Trust investment in Kalvista Pharmaceuticals

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00135143,514.535153,515.53516414414.5415415.5416
Value ($)Share countHistorical KALV position of Bryn Mawr Trust Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Bryn Mawr Trust

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.5k 415 8.47

More positions owned by Bryn Mawr Trust

Comcast Corp Cl A (CMCSA)
Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Vanguard ETF/USA Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Vanguard Etf/usa Total Stk Mkt (VTI)
Procter & Gamble Company (PG)
BlackRock Fund Advisors Rus Tp200 Gr Etf (IWY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
SSgA Funds Management Tr Unit (SPY)
Ishares Core S&p500 Etf (IVV)
Vanguard S&p 500 Etf Shs (VOO)

View all positions for Bryn Mawr Trust

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Suvretta Capital Management
Tang Capital Management
Frazier Life Sciences Management
Vestal Point Capital
Capital World Investors
BlackRock
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Boxer Capital Management
State Street Corporation
Octagon Capital Advisors
Woodline Partners
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals